Vident Advisory, LLC Pfizer Inc Transaction History

Vident Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $2.42 Million - $2.84 Million	95,822 New	95,822 $2.68 Billion
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $103,265 - $134,130	-3,952 Reduced 6.64%	55,541 $1.6 Billion
Q3 2023 Feb 21, 2024	BUY	$32.09 - $37.51 $126,819 - $148,239	3,952 Added 7.12%	59,493 $1.97 Billion
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.91 Million - $2.23 Million	59,493 New	59,493 $1.97 Billion

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.